Events

Caladrius Biosciences will present a company overview. Venue: New York Marriott Marquis Presentation: Corporate Presentation Speaker: David J. Mazzo, PhD, President and Chief Executive Officer

Read More

Due to wildfires in Los Angeles, this conference and presentation date were cancelled.
David J. Mazzo, PhD, President and Chief Executive Officer of the Company, presents at the 10th Annual LD Micro Main Event on Thursday, December 7, 2017 at 10:30 a.m. PST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.

Read More

Venue: Anaheim Convention Center, Anaheim, California
Session: Clinical Studies of Cell Therapy II
Presentation: CD34+ Cells
Speaker: Dr. Douglas W. Losordo

Read More

Venue: The Hilton Waldorf, London, England
Track: Immunology
Presentation: Corporate Presentation
Speaker: David J. Mazzo, Ph.D., President and Chief Executive Officer

Read More

Caladrius’ management will host a conference call for the investment community beginning at 4:30 p.m. ET on Thursday, November 9, 2017, to discuss the financial results, provide a company update and answer questions.

Read More

Venue: Time Warner Center, New York, New York
Session: Put Your Money Where You Heart is – Investing in Novel Cardiovascular Therapies in Myocardial Infarction, Heart Failure and Peripheral Artery Disease
Speaker: Douglas W. Losordo, M.D., FACC, FAHA, Senior Vice President of Clinical Medical and Regulatory Affairs and Chief Medical Officer

Read More

Venue: Estancia La Jolla Hotel & Spa, La Jolla, California
Website: http://www.meetingonthemesa.com 
Presentation: Company Presentation
Speaker: David J. Mazzo, President and Chief Executive Officer, Caladrius

Read More

Venue: Lotte New York Palace Hotel, New York, New York
Website: http://www.meetmax.com/sched/event_39839/~public/conference_home.html?event_id=39839
Presentation: Company Presentation
Speaker: David J. Mazzo, Chief Executive Officer, Caladrius

Read More

Venue: Toranomon Hills Forum, Tokyo, Japan
Website: http://www.tri-kobe.org/events/entry/cd34/detail.html
Panel: CD34+ Cell Therapy for Ischemic Tissue Repair: Two Decades of Evidence
Panelist: Douglas W. Losordo, MD, Chief Medical Officer, Caladrius

Read More

Caladrius’ management hosted a conference call on August 10, 2017 beginning at 4:30 p.m. Eastern Time to review 2017 first quarter financial results, provide a Company update and answer questions.

The archive of the conference call can be accesses on the online via http://clbs.bio/2hGptk2. The webcast will be archived on the Company’s website for 90 days.

Read More

14th International Symposium on Stem Cell Therapy & Cardiovascular Innovations

Venue: Hospital General Universitario Gregorio Maranon, Madrid, Spain
Website: http://cardiovascularcelltherapy.com/wp-content/uploads/2010/06/Preliminary-Agenda.-June-2017-version-reducida-2.pdf

Read More

Date and Time: Tuesday, June 6, 2017, 8:30 AM PT
Venue: Luxe Sunset Hotel, Los Angeles, California
Website: https://www.ldmicro.com/events
Presentation: Company Presentation
Speaker: David J. Mazzo, Chief Executive Officer, Caladrius
Webcast: http://wsw.com/webcast/ldmicro12/clbs

Read More

Caladrius’ management hosted a conference call on May 18, 2017 beginning at 5:00 p.m. Eastern Time to review 2017 first quarter financial results, provide a Company update and answer questions.

The recording can be accessed online at https://engage.vevent.com/rt/caladriusao~20837689

Read More

• Date and Time: Thursday, April 27, 2017, 4:45 PM ET
• Website: http://arminvestorday.com
• Venue: The State Room, Boston, Massachusetts
• Presentation: Company Presentation
• Presenter: David J. Mazzo, PhD, President and Chief Executive Officer, Caladrius

Read More

• Date and Time: Friday, April 7, 9:00 AM ET
• Venue: Millennium Broadway Hotel & Conference Center, New York, New York
• Format: One-on-One Meetings
• Participant: Joseph Talamo, Chief Financial Officer, Caladrius

Read More

Date and Time:Thursday, April 6, 2017, 9:20 AM ET
Venue:Hyatt Regency, Boston, Massachusetts
Plenary:Tolerogenic Therapy for Type 1 Diabetes, A Phase 2 Randomized Study of Autologous Regulatory T-cells Adolescents with Recent Onset T1DM
Speaker:Douglas W. Losordo, MD, Chief Medical Officer, Caladrius

Read More

Date and Time: Thursday, April 6, 1:50 PM ET
Website: https://www.gtcbio.com/conferences/stem-cell-product-development-commercialization/?section=agenda
Venue: Hyatt Regency, Boston, Massachusetts
Presentation: Global Regulation of Cell Therapies
Presenter: William Sietsema, PhD, Executive Director, Global Regulatory Affairs, Caladrius

Read More

• Date and Time: Thursday, March 23, 2017, 1:45 PM PT
• Website: http://www.q1productions.com/ceoforum/day-one/
• Venue: Renaissance San Diego Downtown, San Diego, California
• Panel: What Does Growth Mean to You?
• Panelist: David J. Mazzo, PhD, Chief Executive Officer, Caladrius

Read More

Website: https://alliancerm.org/event/atsummit
Venue: AC Hotel Barcelona Forum, Barcelona, Spain
Session 1

Date and Time: Wednesday, March 22, 2017, 9:00 AM CET
Presentation: Welcome and State of the Industry Remarks
Presenter: Robert Preti, PhD, President, PCT and Chairman, Alliance for Regenerative Medicine
Session 2

Date and Time: Wednesday, March 22, 2017, 3:30 PM CET
Panel: Manufacturing, Industrialization and Infrastructure Roundtable
Panelist: Robert Preti, PhD, President, PCT and Chairman, Alliance for Regenerative Medicine

Read More

Caladrius’ management hosted a conference call for the investment community at 8:30am ET on Friday, March 17, 2017, to discuss the financial results, provide a company update and answer questions.

Read More